Advanced search
Publication Cover
Expert Review of Hematology Volume 6, 2013 - Issue 3
Submit an article Journal homepage
63
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Genetic sequencing studies in Burkitt’s lymphoma: what can we learn about tumorigenesis?

Davide Soldini Hematopathology Section, Department of Anatomic Pathology, Hospital Clinic, University of Barcelona, Barcelona, Spain and Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland
&
Elias Campo Hematopathology Section, Department of Anatomic Pathology, Hospital Clinic, University of Barcelona, Barcelona, Spain. [email protected]
Pages 219-221 | Published online: 10 Jan 2014

References

  • Leoncini L, Raphaël M, Stein H, Harris NL, Jaffe ES, Kluin PM. Burkitt lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL et al. (Eds). IARC, Lyon, France, 262–264 (2008).
  • Magrath I. Towards curative therapy in Burkitt lymphoma: the role of early African studies in demonstrating the value of combination therapy and CNS prophylaxis. Adv. Hematol. 2012, 130680 (2012).
  • Burkitt D. A sarcoma involving the jaws in African children. Br. J. Surg. 46(197), 218–223 (1958).
  • Magrath I. Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br. J. Haematol. 156(6), 744–756 (2012).
  • Sander S, Calado DP, Srinivasan L et al. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell 22(2), 167–179 (2012).
  • Hummel M, Bentink S, Berger H et al.; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. A biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 354(23), 2419–2430 (2006).
  • Dave SS, Fu K, Wright GW et al.; Lymphoma/Leukemia Molecular Profiling Project. Molecular diagnosis of Burkitt’s lymphoma. N. Engl. J. Med. 354(23), 2431–2442 (2006).
  • Richter J, Schlesner M, Hoffmann S et al.; ICGC MMML-Seq Project. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat. Genet. 44(12), 1316–1320 (2012).
  • Love C, Sun Z, Jima D et al. The genetic landscape of mutations in Burkitt lymphoma. Nat. Genet. 44(12), 1321–1325 (2012).
  • Schmitz R, Young RM, Ceribelli M et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418), 116–120 (2012).
  • Quong MW, Romanow WJ, Murre C. E protein function in lymphocyte development. Annu. Rev. Immunol. 20, 301–322 (2002).
  • Seitz V, Butzhammer P, Hirsch B et al. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS ONE 6(11), e26837 (2011).
  • Soldini D, Montagna C, Schüffler P et al. A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. Ann. Oncol. 24(1), 193–201 (2013).
  • Soldini D, Campo E. New insights into the diagnosis of lymphomas. Ann. Oncol. 23(Suppl. 10), 83–88 (2012).
  • Landau DA, Carter SL, Stojanov P et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152(4), 714–726 (2013).
  • Puente XS, López-Otín C. The evolutionary biography of chronic lymphocytic leukemia. Nat. Genet. 45(3), 229–231 (2013).
  • Kirk R. Targeted therapies: new targets in Burkitt lymphoma? Nat. Rev. Clin. Oncol. 9(10), 551 (2012).
  • Rodon J, Dienstmann R, Serra V, Tabernero J. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat. Rev. Clin. Oncol. 10(3), 143–153 (2013).
  • Young RM, Staudt LM. Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat. Rev. Drug Discov. 12(3), 229–243 (2013).
  • Cicenas J, Valius M. The CDK inhibitors in cancer research and therapy. J. Cancer Res. Clin. Oncol. 137(10), 1409–1418 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.